Crohn's Disease Clinical Trials in Hartford, Connecticut

4 studies are recruiting for crohn's disease in Hartford, Connecticut right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

    The purpose of this study is to evaluate the clinical and endoscopic efficacy of guselkumab in pediatric participants with Crohn's Disease (CD) at the end of maintenance therapy (Week 52) among participants who were in clinical response to guselkumab at Week 12.

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    Connecticut Children's Medical Center, Hartford, Connecticut
    Locations
    85 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT05923073 on ClinicalTrials.gov

  2. A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

    The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (CD). The study will last about 172 weeks and may include up to 44 visits. Additional treatment may be available to participants via a Contin…

    Stage
    Phase 3
    Ages
    2 to 19
    Site
    Connecticut Children's Medical Center, Hartford, Connecticut
    Locations
    68 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT04844606 on ClinicalTrials.gov

  3. A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

    Study participants will be screened during the platform study and randomly assigned to receive mirikizumab or another intervention. The purpose of the mirikizumab study is to evaluate efficacy, safety, tolerability, and how well mirikizumab absorbs into the body of pediatric participants with Crohn…

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    Connecticut Children's Medical Center, Hartford, Connecticut
    Locations
    81 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT05509777 on ClinicalTrials.gov

  4. Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

    Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most often affecting the bowels. It can cause many different symptoms including abdominal pain, diarrhea, tiredness, and weight loss. This study will assess how safe and effec…

    Stage
    Phase 3
    Ages
    2 to 17
    Site
    Connecticut Children's Medical Center - Hartford /ID# 262256, Hartford, Connecticut
    Locations
    85 in total
    Run by
    AbbVie

    See if you can join NCT06332534 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.